Eli Lilly & Co. (LLY)

Solid dividend. News from expiring patents has expired.

I would recommend googling Simpsonwood document, which shows that the CDC and vaccine manufacturers were aware of mounting evidence that vaccines are linked to autism. Add to this a new scientific report that shows a link between neurological damage and vaccines for adults, which will set the stage for litigation by veterans who suffer from Gulf War Syndrome.

Eli Lilly owns the patent to Thimerasol, a deadly neurotoxin that is still used in flu shots and vaccines exported to third world countries. Adjuvant such as aluminium and squaline may help Eli cut costs, but the proof of detrimental side effects is mounting. I see large class action law suits piling up soon in the next couple of years.

The balance sheet hurts my eyes to look at. The numbers are so large I have a hard time wrapping my head around the dynamics of a company of that size. No less a pharmaceutical company. What I do understand is that the dividend is unfazed. It hasn't seen any runs on pricing. In my mind it's not so much a hot stock as a great 5 year CD. Start 34.15 Stop 28.60

Solid Company

technical breakout

5.9% dividend

Mmm...pharmaceuticals...

Portefeuille 12. Hoping Eli Lilly will benefit if I am correct in my assumption that medical stocks are next up for big gains.

div

Long term pharma with some dividends...good entry I believe

As of July 10, 2009, part of the Morningstar Wide Moat Focus index, which tracks the 20 wide-moat firms wide the lowest price-to-fair value ratio. Firms are selected from 174 companies defined as "wide-moat" by Morningstar.

Fair value estimate is listed as $54.
http://news.morningstar.com/articlenet/article.aspx?id=298017

I sometimes wonder how it is that a pharmaceutical stock classifiies as a wide-moat. Yes, they have patent protection, but you know there are many competitors developing new drugs in the same class and the moat will last only as long as the patents (or the tricks that they can use to extend the life of those patents). Maybe "temporary-moat" would be a better term for firms that rely on patent protection for their competitive advantage.

This stock was chosen as part of a group of stocks based upon criteria which focused heavily on dividend yield, cash flow, and balance sheet information.

MY BROKER RECOMMENDED AND HAVE HELD FOR 5 YEARS

Great dividend!!!!!!!

byetta that diabetes drug should light things up....in about a year.

What's better for a depression than antidepressants?

Dividends, Health Care and drugs for aging population. Plenty of money to buy other companies and develop new drugs.

Eli Lily is one of the best and most consistently well managed companies. It understand the ebb and tides.

excellent company and should return to it's highs as the market gets better